Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 12 studies | 22% ± 7% | |
| ciliated cell | 4 studies | 26% ± 4% | |
| endothelial cell of lymphatic vessel | 4 studies | 21% ± 2% | |
| GABAergic neuron | 4 studies | 29% ± 11% | |
| glutamatergic neuron | 4 studies | 36% ± 13% | |
| epithelial cell | 3 studies | 24% ± 5% | |
| hepatocyte | 3 studies | 40% ± 20% | |
| enteroendocrine cell | 3 studies | 27% ± 10% | |
| interneuron | 3 studies | 28% ± 14% | |
| neuron | 3 studies | 25% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 24% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 1604.76 | 21 / 21 | 100% | 13.24 | 504 / 504 |
| breast | 100% | 1959.17 | 459 / 459 | 100% | 13.23 | 1118 / 1118 |
| intestine | 100% | 1550.69 | 966 / 966 | 100% | 10.49 | 527 / 527 |
| prostate | 100% | 1807.35 | 245 / 245 | 100% | 16.34 | 502 / 502 |
| uterus | 100% | 1760.58 | 170 / 170 | 100% | 12.19 | 459 / 459 |
| esophagus | 100% | 2463.65 | 1444 / 1445 | 100% | 10.93 | 183 / 183 |
| skin | 100% | 2046.22 | 1809 / 1809 | 100% | 10.97 | 471 / 472 |
| kidney | 100% | 1673.43 | 89 / 89 | 100% | 11.25 | 899 / 901 |
| ovary | 100% | 972.01 | 180 / 180 | 100% | 6.60 | 429 / 430 |
| liver | 100% | 3041.64 | 226 / 226 | 100% | 9.27 | 405 / 406 |
| thymus | 100% | 1771.21 | 653 / 653 | 100% | 8.23 | 603 / 605 |
| brain | 99% | 2743.21 | 2623 / 2642 | 100% | 14.33 | 705 / 705 |
| lung | 100% | 1532.81 | 576 / 578 | 99% | 8.54 | 1149 / 1155 |
| stomach | 99% | 923.37 | 356 / 359 | 100% | 9.31 | 285 / 286 |
| adrenal gland | 100% | 1726.38 | 258 / 258 | 99% | 12.79 | 227 / 230 |
| pancreas | 98% | 825.83 | 322 / 328 | 100% | 11.57 | 178 / 178 |
| adipose | 100% | 1767.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 9.21 | 29 / 29 |
| spleen | 100% | 2904.65 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 9.66 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.20 | 1 / 1 |
| blood vessel | 100% | 1059.14 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 8.55 | 79 / 80 |
| peripheral blood | 98% | 1349.71 | 910 / 929 | 0% | 0 | 0 / 0 |
| heart | 95% | 677.22 | 819 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 748.74 | 758 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0005576 | Cellular component | extracellular region |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0016491 | Molecular function | oxidoreductase activity |
| GO_0000166 | Molecular function | nucleotide binding |
| Gene name | GFOD2 |
| Protein name | Glucose-fructose oxidoreductase domain containing 2 Glucose-fructose oxidoreductase domain-containing protein 2 Glucose-fructose oxidoreductase domain-containing protein 2 (EC 1.-.-.-) |
| Synonyms | UNQ9430/PRO34691 |
| Description | FUNCTION: Promotes matrix assembly. . FUNCTION: Promotes matrix assembly. . FUNCTION: Promotes matrix assembly. . |
| Accessions | ENST00000602279.2 [Q3B7J2-3] ENST00000602496.1 [Q3B7J2-3] ENST00000602377.1 Q3B7J2 A0A087WT49 ENST00000602855.2 ENST00000602627.1 ENST00000268797.12 [Q3B7J2-1] A0A087WTD9 A0A087X156 |
